Skip to Main Content
Contact Us
Category: Ovarian
Accelerating Approval Pathway For Phase III Ovarian Cancer Trial A late-stage biotech was developing a combination therapy for a rare form of ovarian cancer. It is challenging to diagnose, difficult to treat due to its chemo-resistance, and at the time, there were no approved treatments specifically for this indication. Read Now Abdominal pain patient woman having medical exam with doctor; potentially has ovarian cancer Developing Cutting-edge Treatments for Ovarian Cancer Ovarian cancer is the second most common gynecological cancer worldwide and carries the highest mortality Read Now Professional man explaining to others at whiteboard Global Full-service Phase III Ovarian Cancer Study Catalyst Oncology succeeds in delivering for late clinical-stage oncology biotech. While the biotech had experience Read Now
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.